[Value of thymidine kinase in the prediction of response to treatment by chemotherapy or hormone therapy in breast cancer].

Abstract:

:Thymidine kinase (TK) was assayed in the cytosol of 210 primary breast cancers to assess its predictive value for response to first line chemotherapy and hormonotherapy. We performed correlations between TK and the other prognosis factors of breast cancer. TK activity is correlated with SBR grading and estrogen receptors. It has a low predictive value for response to chemotherapy and is not useful for hormonotherapy.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Bennini N,Mauriac L,Wafflart J,Bonichon F,Durand M

subject

Has Abstract

pub_date

1992-01-01 00:00:00

pages

773-9

issue

8

eissn

0007-4551

issn

1769-6917

journal_volume

79

pub_type

杂志文章
  • [Transforming Growth Factor Beta: structure, biologic effects and mechanism of action].

    abstract::For more than a decade, Transforming Growth Factor Beta (TGF beta) has been intensively studied. Such studies have led to the identification of many related polypeptides which constitute the TGF beta family. These factors modulate many animal cell processes such as cell cycle progression, differentiation, adhesion, mi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Benzakour O

    更新日期:1994-12-01 00:00:00

  • [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].

    abstract::The authors present 143 cases of breast carcinoma T1 and T2, N0, N1, N2 and N3 without clinical signs of bone metastasis. They study the value of bone scintigraphy with technetium 99m labelled diphosphonates. One hundred and twelve patients had normal bone scans; 31 patiets showed abnormal fixation sites: in 23 (16%) ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Stines J,Stalars J,Dartois D,Chardot C

    更新日期:1980-01-01 00:00:00

  • [The cost of radiotherapy].

    abstract::The higher human and material costs induced by the development of conformal radiotherapy and other innovative techniques have to be evaluated. Different studies reflect benefit for three-dimensional conformal radiation therapy. This needs appropriate economic analyses (cost/benefit, cost/utility). Conclusions from stu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Martin P

    更新日期:2003-11-01 00:00:00

  • [Breast cancer screening: On our way to the future].

    abstract::Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important improvements in prognosis over the past 20 years, breast cancer scree...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.06.005

    authors: Delaloge S,Bachelot T,Bidard FC,Espie M,Brain E,Bonnefoi H,Gligorov J,Dalenc F,Hardy-Bessard AC,Azria D,Jacquin JP,Lemonnier J,Jacot W,Goncalves A,Coutant C,Ganem G,Petit T,Penault-Llorca F,Debled M,Campone M,Levy

    更新日期:2016-09-01 00:00:00

  • [ALL in adult patients: Contribution and limits of pediatric management].

    abstract::For two decades, the prognostic of adult patients with ALL was improved based on pediatric-inspired protocols. These approaches based on less myelosuppressive drugs have led to improved response rates, decreased relapse rates, with a benefit in survival observed in patients aged up to 50-60-years-old. Therapeutic inte...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.07.008

    authors: Rabian F,Boissel N

    更新日期:2020-09-24 00:00:00

  • [Prognostic factors in endometrial cancer: apropos of 206 cases treated at the Curie Institute].

    abstract::From January 1, 1983 to December 31, 1990 two hundred and six patients with an invasive, non metastatic endometrial carcinoma were first treated at Institut Curie. Initial tumoral staging (TNM) was as follows: stage Ia: 48%, stage Ib: 31%, stage II: 15% and stage III-IV: 6%. Total hysterectomy or colpohysterectomy was...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chen Q,de la Rochefordière A,Mouret-Fourme E,Durand JC,Clough K,Asselain B,Labib A,Fenton J

    更新日期:1995-09-01 00:00:00

  • [Insufficient efficacy of the use of a single 8 mg tablet of ondansetron in the prevention of nausea and vomiting induced by FEC chemotherapy].

    abstract::This study was performed in a group of 89 patients treated for breast carcinoma with a FEC regimen (5-fluorouracil, epirubicin, cyclophosphamide). The aim was to evaluate the antiemetic efficacy of one 8 mg tablet ondansetron (OND), and in case of failure, to measure the recovering level by the administration of 8 mg ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hebbar M,Hecquet B,Vanlemmens L,Lecomte S,Pion JM,Adenis A,Bonneterre J

    更新日期:1995-01-01 00:00:00

  • [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,病人教育讲义

    doi:

    authors: Bourguet P,Brusco S,Corone C,Devillers A,Foehrenbach H,Lumbroso JD,Maszelin P,Montravers F,Moretti JL,Rain JD,Talbot JN,Carretier J,Leichtnam-Dugarin L,Delavigne V,Philip T,Fervers B,Fédération nationale des centres de lu

    更新日期:2005-07-01 00:00:00

  • [Irinotecan for the treatment of metastatic colorectal cancer].

    abstract::In a dozen years of development, irinotecan (CPT11) became one of major therapeutics in the taking care of the metastatic colorectal cancer (CCRM). First used in monotherapy every three weeks, irinotecan has been later developed in association with 5FU and folinic acid according to two modalities of administration (bo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Assenat E,Duffour J,Ychou M

    更新日期:2006-05-01 00:00:00

  • [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

    abstract::Haploidentical hematopoietic stem cell transplantation (HSCT) is being increasingly used due to improvement of the transplantation procedures allowing a reduction of graft-versus-host-disease (GVHD) and of transplant-related mortality (TRM). Such improvements have been particularly observed after administration of T-r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2016.09.007

    authors: Nguyen S,Chalandon Y,Lemarie C,Simon S,Masson D,Dhedin N,Suarez F,Renaud B,Charbonnier A,Yafour N,François S,Duléry R,Blaise D,Yakoub-Agha I,Rubio MT

    更新日期:2016-11-01 00:00:00

  • [Retrospective study about 20 cases of ovarian Burkitt lymphoma at Yopougon teaching hospital in Côte d'Ivoire].

    abstract:CONTEXT:The maxillo-facial attack was the first described in the Burkitt lymphoma in 1958 by Denis Pearsons Burkitt. Abdominopelvic disorders, particularly ovarian localization are observed more and more by the developments of imagery technics. Our study aimed to describe the epidemiologic, clinical, therapeutic and ev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.12.011

    authors: Kouakou B,Kamara I,Silue AD,Meite N,Botti RP,Tolo-Diebkile A,Sanogo I

    更新日期:2019-03-01 00:00:00

  • [Molecular aspects of head and neck, and lung cancer oncogenesis].

    abstract::Lung and head and neck cancers result from a multistep process involving activation of oncogenes and inactivation of tumor-suppressor genes. These two processes share common features and molecular players, while their corresponding clinical entities are both triggered by the tobacco carcinogens. In many cases, the mol...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0786

    authors: Loriot Y,Mordant P,Fouret P,Deutsch E,Soria JC

    更新日期:2009-01-01 00:00:00

  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal].

    abstract::Beside human papilloma virus infection, several genetic factors have been involved in susceptibility to cervical cancer. The arginine allele at codon 72 in p53 tumor suppressor gene has been reported to be a risk-factor in different ethnic groups. Our aim was to study this polymorphism as a risk-factor in Senegal. We ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1911

    authors: Ndiaye R,Dem A,Mbaye PM,Guèye PM,Diop G,Diop PA,Faye O

    更新日期:2014-09-01 00:00:00

  • Detailed overview on rare malignant ovarian tumors.

    abstract::The group of rare malignant ovarian tumors includes the group of germ cell tumors, sex cords stromal ovarian tumors, small cell carcinoma, malignant Brenner tumors, rare epithelial tumors such as mucinous carcinoma, clear cell carcinoma, or low-grade serous carcinoma, as well as ovarian carcinosarcoma. Together they c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.01.011

    authors: Aust S,Eberst L,Tredan O,Rousset-Jablonski C,Treilleux I,Méeus P,Chopin N,Beurrier F,Charreton A,Véronique D,Hallouz A,Coulon A,Ricoeur A,Mastier C,Bouhamama A,Racadot S,Devouassoux-Shisheboran M,Haddad V,Ray-Coquard

    更新日期:2020-03-01 00:00:00

  • [Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region].

    abstract::Oncotype DX® has been validated as quantifying the likelihood of distant recurrence at 10 years and overall chemotherapy benefit in patients with estrogen-receptor-positive and HER-2-negative early breast cancer. In 2012, this genomic signature was routinely available for patients in Franche-Comté, France. Patients el...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1923

    authors: Nerich V,Curtit E,Bazan F,Montcuquet P,Villanueva C,Chaigneau L,Cals L,Méneveau N,Dobi E,Altmotlak H,Algros MP,Choulot MJ,Nallet G,Limat S,Mansion S,Pivot X

    更新日期:2014-07-01 00:00:00

  • [Cell signalling and cancer].

    abstract::Cell signalling represents the network of cell communication pathways. Reception of a message by a cell results in the implementation of various direct and indirect actions, especially through the transcription of the genes required for carrying out the orders received. The signals exchanged by cells may concern proli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1199

    authors: Robert J

    更新日期:2010-11-01 00:00:00

  • [Clinical development of anti-angiogenic agents in 2002].

    abstract::In 2002, new developments in anti-angiogenic strategies encompassed two main aspects. Firstly, essential improvements were made in the field of methodology : novel techniques permitted to measure directly on patients the biological effects induced by anti-angiogenic treatments in the course of clinical trials. Secondl...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachelot T,Jouanneau E,Blay JY

    更新日期:2003-01-01 00:00:00

  • [CD44 expression: a new prognostic factor in neuroblastoma].

    abstract::CD44 gene products are potential markers of aggressiveness in different tumor models, a result which prompted us to study clinical neuroblastoma (NB) specimens. CD44 expression was determined by immunostaining of 52 NB with a monoclonal antibody (J173) directed against an epitope common to all CD44 isoforms. All tumor...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Combaret V,Lasset C,Bouvier R,Frappaz D,Thiesse P,Rebillard AC,Philip T,Favrot MC

    更新日期:1995-01-01 00:00:00

  • [Mendelian genetics and cancer (author's transl)].

    abstract::Two hundred different mendelian genes can have a cancerogenic effect in man, but it is difficult to make out between the genetic and the environmental part. Acute lymphoblastic leukemia is an example that the actual cancerogenic factor can be environmental and not genetic. Genetically controlled tumors can result from...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Amiel JL

    更新日期:1978-01-01 00:00:00

  • [Prostate cancer: update].

    abstract::The study of mitotic transduction of the signal showed that overexpression of pAkt and reduction in pERK expression would be associated a biological relapse. For tumors T1-3 N0M0 at the high risk of local relapse after prostatectomy, an immediate radiotherapy compared with a differed radiotherapy (at the time of PSA r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Oudard S,Medioni J,Scotté F,Banu E

    更新日期:2005-10-01 00:00:00

  • [Angiogenin: involvement in angiogenesis and tumour growth].

    abstract::Angiogenin is one of the most potent inducers of neovascularization in experimental models in vivo. Angiogenin is normally present in plasma but overexpressed in cancer patients. The possible involvement of angiogenin in the development of cancer is suggested by its overexpression in patients with a variety of tumours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pavlov N,Badet J

    更新日期:2001-08-01 00:00:00

  • [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].

    abstract::At the time of diagnosis, central nervous system (CNS) involvement is identified in less than 10% of adult acute lymphoblastic leukemia (ALL). Long-term disease-free survival can be achieved in these patients. CNS disease at presentation does not appear to be an independent poor prognostic factor. In CNS leukemia, inn...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0645

    authors: Thomas X,Pavan L,Le QH

    更新日期:2008-07-01 00:00:00

  • [Image guided radiation therapy (IGRT)].

    abstract::Image guided radiation therapy (IGRT) is a major technical innovation of radiotherapy. It allows locating the tumor under the linear accelerator just before the irradiation, by direct visualization (3D mode soft tissue) or indirect visualization (2D mode and radio-opaque markers). The technical implementation of IGRT ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1140

    authors: Lagrange JL,de Crevoisier R

    更新日期:2010-07-01 00:00:00

  • Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

    abstract::This study determined the prevalence and the prognostic value of the expression of microtubule components in tumors of 19 patients with non small cell lung cancer receiving taxane-based regimens. Patient samples were stained with antibodies directed against total beta tubulin, classes I, II and III beta tubulin isotyp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dumontet C,Isaac S,Souquet PJ,Bejui-Thivolet F,Pacheco Y,Peloux N,Frankfurter A,Luduena R,Perol M

    更新日期:2005-02-01 00:00:00

  • [Prevention and treatment of antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: An update].

    abstract::Antineoplastic drug induced nausea and vomiting are common adverse events in cancer care of paediatric patients ; therefore, prevention and management of these adverse events is a major concern for healthcare professionals. There are common features between paediatric and adult patients in terms of the emetogenic leve...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.03.015

    authors: Delmotte M,Mouffak S,Mongaret C,Michelet-Huot E,Roques G,Slimano F

    更新日期:2020-01-01 00:00:00

  • [Methodological and ethical quality in phase III cancer trials: role of the cooperative group].

    abstract::Phase III clinical trials (CT) are carried out more and more often in a multicentric way, under the aegis of one or more cooperative groups (CG). The goal of this study was to analyze the influence of the GC on ethical quality (EQ) and methodological quality (MQ) in phase III cancer CT. EQ (Berdeu-score) and MQ (Jadad...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tuech JJ,Pessaux P,Moutel G,Thoma V,Schraub S,Hervé C

    更新日期:2004-10-01 00:00:00

  • [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].

    abstract::In our hospital, most of the patients with a cancer received palliative chemotherapy. Then, we wanted to know in which conditions these therapies were realised and most specially for patients with lung cancer. We noted the stage of the disease at the diagnosis, the median survival duration after diagnosis and the medi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Demange C,Thiébaux I

    更新日期:2003-03-01 00:00:00

  • [Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives].

    abstract::Treatment of patients with small-cell lung cancer (SCLC) remains disappointing despite high initial complete response rates. The dramatic initial chemosensitivity of tumor cells is frustrated by the early emergence of chemoresistant clonogenic cells, regardless of front line treatments. Although the dose relationship ...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,meta分析,随机对照试验

    doi:

    authors: Le Chevalier T,Le Cesne A,Arriagada R

    更新日期:1995-01-01 00:00:00

  • C cell hyperplasia.

    abstract::The evidence that C cell hyperplasia is the precursor of medullary carcinoma in families where this tumour is inherited is very strong. It is suggested that the tumour is the result of at least two mutations, in the families with medullary carcinoma the first of these is genetically determined, and the second is an ac...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Williams ED

    更新日期:1984-01-01 00:00:00